Horizon Therapeutics Public Ltd Co Amortization of Intangible Assets in USD from 2011 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Horizon Therapeutics Public Ltd Co quarterly/annual Amortization of Intangible Assets history and growth rate from 2011 to Q2 2023.
  • Horizon Therapeutics Public Ltd Co Amortization of Intangible Assets for the quarter ending June 30, 2023 was $89.6M, a 1.86% decline year-over-year.
  • Horizon Therapeutics Public Ltd Co Amortization of Intangible Assets for the twelve months ending June 30, 2023 was $364M, a 0.58% increase year-over-year.
  • Horizon Therapeutics Public Ltd Co annual Amortization of Intangible Assets for 2022 was $367M, a 8.98% increase from 2021.
  • Horizon Therapeutics Public Ltd Co annual Amortization of Intangible Assets for 2021 was $336M, a 31.8% increase from 2020.
  • Horizon Therapeutics Public Ltd Co annual Amortization of Intangible Assets for 2020 was $255M, a 10.7% increase from 2019.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)

Horizon Therapeutics Public Ltd Co Quarterly Amortization of Intangible Assets (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $364M $89.6M -$1.7M -1.86% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $366M $88.6M -$700K -0.78% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $367M $92.9M +$1.91M +2.1% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 $365M $93M +$2.58M +2.86% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $362M $91.3M +$2.78M +3.14% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $359M $89.3M +$22.9M +34.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $336M $91M +$26.6M +41.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 $310M $90.4M +$25M +38.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $285M $88.5M +$21.8M +32.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $263M $66.4M +$7.79M +13.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $255M $64.4M +$6.76M +11.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $248M $65.4M +$7.69M +13.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $241M $66.7M +$9.07M +15.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $232M $58.6M +$1.16M +2.02% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $230M $57.7M -$3.47M -5.67% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $234M $57.7M -$3.48M -5.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $237M $57.7M -$2.8M -4.63% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $240M $57.4M -$3.47M -5.69% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $244M $61.1M +$19.8M +48% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 $224M $61.1M -$7.52M -11% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $231M $60.5M -$9.3M -13.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $241M $60.9M -$8.82M -12.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $249M $41.3M -$24.1M -36.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $274M $68.7M +$17.9M +35.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $256M $69.8M +$19M +37.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $237M $69.7M +$20M +40.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $217M $65.4M +$23.7M +56.8% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $193M $50.8M +$9.1M +21.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 $184M $50.8M +$19M +59.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $165M $49.7M +$32M +181% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $133M $41.7M +$25.8M +162% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 $107M $41.7M +$35.3M +552% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $71.8M $31.8M +$26.8M +536% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $45M $17.7M +$12.7M +254% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $32.3M $15.9M +$12.8M +409% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $19.5M $6.4M +$4.72M +281% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $14.8M $5M +$3.36M +205% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $11.4M $5M +$3.34M +202% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $8.1M $3.12M Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $1.68M +$339K +25.3% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $1.64M +$785K +91.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $1.66M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q3 2012 $1.34M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $856K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09

Horizon Therapeutics Public Ltd Co Annual Amortization of Intangible Assets (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $367M +$30.2M +8.98% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-01
2021 $336M +$81.2M +31.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 $255M +$24.7M +10.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $230M -$13.2M -5.42% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $244M -$5.82M -2.33% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $249M +$32.8M +15.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $217M +$83.8M +63.1% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $133M +$101M +311% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-28
2014 $32.3M +$24.2M +299% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
2013 $8.1M +$3.4M +72.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $4.7M +$947K +25.2% Jan 1, 2012 Dec 31, 2012 10-K/A 2015-03-02
2011 $3.75M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.